Iguchi, Satoshi
Moriguchi, Tetsuaki
Yamazaki, Makoto
Hori, Yuki
Koshino, Kazuhiro
Toyoda, Kazunori
Teuho, Jarmo
Shimochi, Saeka
Terakawa, Yusuke
Fukuda, Tetsuya
Takahashi, Jun C.
Nakagawara, Jyoji
Kanaya, Shigehiko
Iida, Hidehiro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15jm0310001h0003)
Ministry of Health, Labour and Welfare (H22-Noninvasive-002)
Article History
Received: 13 September 2018
Accepted: 28 November 2018
First Online: 19 December 2018
Authors’ information
: TM is on the leave to University of Tsukuba Tandem Accelerator Complex, 1-1-1 Tenno-dai, Tsukuba City, Ibaraki, Japan. MY is on the leave to Nihon Institute of Medical Science, 1276 Shimokawara, Moroyamamachi, Irumagun, Saitama, Japan. YH is on the leave to Robert Research Institute, University of Western Ontario, Canada.
: The retrospective data analysis was approved by the Ethics Committee at the authors’ institution. The radiosynthesis device was approved as a medical device in Japan (22400BZX00441000) on 21 November 2012.
: All participants gave written informed consent before entry into the study.
: HI is a patent inventor of the two-hole two-layered face mask and the rapid radiopharmaceutical synthesis/inhalation system. He also received a research grant from JFE, Tokyo, Japan and Molecular Imaging Labo, Suita City, Osaka, Japan. YH is also a patent co-inventor of the two-hole two-layered face mask. All other authors have no conflict of interest to disclose, financial or otherwise.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.